.png){kind=icon}
.png){kind=icon}
Return
Right ventricular-centered metabolomics: A promising tool for phenotyping pulmonary arterial hypertension
.png){kind=icon}
PRE
AI
V
P
C
DOI：10.1016/j.cca.2026.121025.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Recent advances in plasma metabolomics have highlighted the potential role of right ventricular-centered metabolic profiling in pulmonary arterial hypertension associated with atrial septal defect. By commenting on a trans-cardiac metabolomic gradient approach, this letter discusses how right ventricular metabolic signatures may reflect adaptive and maladaptive mechanisms beyond hemodynamic burden alone. We contextualize these findings within emerging evidence from lipidomics, endothelial biomarkers, and systemic disease models, emphasizing the translational value of integrating metabolomics into phenotyping and risk stratification strategies for pulmonary hypertension.
Keywords:
Right ventricle
Metabolomics
Pulmonary arterial hypertension
Biomarkers
Phenotyping
Journal
IF:
2.9
Papers:
1.5W
Citations:
2.1W
Organization
Cited Papers